Please try another search
Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate, AMX003 (sodium phenylbutyrate and taurursodiol, also known as ursodoxicoltaurine) for the treatment of amyotrophic lateral sclerosis (ALS). The Company is developing AMX0035 for other neurodegenerative diseases by leveraging knowledge and relationships in the neurodegenerative space. AMX0035 is a dual unfolded protein response (UPR)-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). Its development of antisense oligonucleotides (ASOs), including lead ASO AMX0114, which targets calpain-2 (CAPN2), a gene encoding calcium-dependent proteolytic enzyme which has been implicated in the pathogenesis of ALS and other neurodegenerative diseases.
Name | Age | Since | Title |
---|---|---|---|
Joshua Cohen | 30 | 2013 | Co-Founder, Co-CEO & Director |
Justin Klee | 31 | 2013 | Co-Founder, Co-CEO & Director |
Rudolf Emile Tanzi | 63 | - | Chairman of The Scientific Advisory Board |
George Mclean Milne | 79 | 2015 | Independent Chairman of the Board |
Walter A. Gilbert | 90 | 2016 | Special Advisor & Member of Advisory Board |
Alan Edmund Walts | 61 | 2017 | Board Observer & Advisor |
Sasha H. Bakhru | - | - | Member of Scientific Advisory Board |
Paul R. Fonteyne | 63 | 2021 | Independent Director |
Daphne E. Quimi | 56 | 2021 | Independent Director |
Karen Mindy Firestone | 67 | 2023 | Independent Director |
Peter B. Finn | - | - | Company Secretary & Member of Scientific Advisory Board |
Bernhardt G. Zeiher | 60 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review